Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00419627
Collaborator
Technion, Israel Institute of Technology (Other)
160
1
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the presence of proteins in solid tumors which may lead to an immune response
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The main objective of the study is to evaluate which proteins are presented by the HLA complex of solid tumors. Secondary objectives include to evaluate whether an immune response specific to these proteins has actually been provoked and whether there is a similar immune response following recurrence. Real specimens will be evaluated using PCR and mass spectrometry.
Study Design
Study Type:
Observational
Observational Model:
Natural History
Time Perspective:
Prospective
Official Title:
Proteomic Analysis of Serology and Peptides Presented on the HLA Complex of Breast, Ovarian, Colon, Rectal, Gastric and Pancreatic Adenocarcinoma.
Study Start Date
:
Feb 1, 2007
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas
Exclusion Criteria:
-
Withdrawal of consent
-
Small specimen which does not allow to retrieve tissue without interfering with pathologic evaluation
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hillel Yaffe Medical Center | Hadera | Israel | 38100 |
Sponsors and Collaborators
- Hillel Yaffe Medical Center
- Technion, Israel Institute of Technology
Investigators
- Principal Investigator: Itamar Ashkenazi, M.D., Hillel Yaffe Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00419627
Other Study ID Numbers:
- ProtHYMC
First Posted:
Jan 8, 2007
Last Update Posted:
Jan 8, 2007
Last Verified:
Jan 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: